GENE ONLINE|News &
Opinion
Blog

2022-01-17|

ARM 2022: Industry Briefs on Cell and Gene Therapies

by Sahana Shankar
Share To
One global network, the Alliance for Regenerative Medicine (ARM), represents 400 members from industry and academia in advocating for innovations and support of cell, gene, tissue-based advanced therapies. At the ARM’s virtual 2022 Cell & Gene State of the Industry Briefing, two experts highlighted the sector’s progress in 2021 and welcomed industry experts to share their views on the promising future of regenerative medicine in 2022 and 2023. The speakers are: 

It's free! Log in now to read

LATEST
NICE Approves First-Ever Daily Pill for Endometriosis Treatment
2025-03-20
Fast-Tracking Biotech Innovation: How ITRI Is Overcoming Bottlenecks and Fueling Taiwan’s Global Startup Boom
2025-03-19
AI’s Promise to Profits: How IBM is Maximizing Business ROI with Accelerated Computing
2025-03-19
Edge Computing: The Next Big Thing in AI and Automation
2025-03-19
Novo Nordisk Rejoins British Pharmaceutical Industry Association After Suspension
2025-03-19
Study Links Cigars, Pipes, and Smokeless Tobacco to Increased Heart Disease Risk
2025-03-19
Radar Device Developed to Detect Early Signs of Heart Problems
2025-03-19
EVENT
2025-04-21
World Vaccine Congress Washington 2025
Washington, U.S.A
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
2025-04-26
SABPA OC/LA 17th Annual Biomedical Forum
Irvine, California, United States
2025-05-03
29th Taiwan Joint Cancer Conference 2025
Taipei, Taiwan
Scroll to Top